GSK has signed a joint sales contract with two domestic companies, GC Pharma and Kwang Dong, to sell the shingles vaccine Shingrix. GSK Korea announced on the 24th that it signed a Co-Promotion and Distribution Partnership for Shingrix's domestic sales and marketing on the 21st.

Through this partnership, GC Pharma and Kwang Dong will jointly promote GSK's new shingles vaccine Shingrix on all distribution channels, including hospitals. GSK subsidiary is expected to strengthen its expertise in the distribution of shingles vaccines by selecting GC Pharma and Kwang Dong, which have domestic sales networks and marketing know-how accumulated in the shingles vaccine sector. "We are pleased to introduce a shing